Direct medical costs associated with HAIs = $28B per year The need for effective strategies to reduce the rate of infection and spread of germs, bacteria, viruses and pathogens is apparent following the events of the past three years.
Even prior to the pandemic, hospital-acquired infections were associated with both high morbidity and high costs as the direct medical costs associated were at least US$28.4 billion per year in 2015.
The need for a solution to this is clear and FendX Technologies (FNDX.c) provides exactly that with its RepelWrap, a first-of-its-kind product with patent-pending and proprietary technology to repel bacteria and viruses and reduce their spread.
RepelWrap is the first and only coating that repels viruses and bacteria upon touch, stopping any contamination after contact, differing from other products that attempt to kill the bacteria and viruses.
As the surface coating market is estimated to hit US$3.5 billion by 2025, growing from US$1.3 billion in 2020 at an 18% CAGR, this is a significant market opportunity.
With plans to enter commercial production and commence significant revenue generation in 2024, FNDX has significant potential with a stacked management team, a strong share structure and tight float making it one to consider.
For more information,check out FNDX's website & fact sheet: https://fendxtech.com/
https://fendxtech.com/wp-content/uploads/2023/03/FendX_Factsheet_March20a.pdf
Posted on behalf of FendX Technologies Inc.